CHICAGO – Oncology informatics startup Vidence has publicly emerged as an independent company after spending its formative years as the data analytics division of Cancer Center Treatment Centers of America Global (CTCA). The Boca Raton, Florida-based company officially took its own identity in March and publicly launched last month.
Cofounder, President, and CEO Percy Van Crocker said that the independence will allow the company to partner with hospitals that might otherwise see CTCA as a competitor.